Schmidt, Götz
Schneck, Emmanuel
Edinger, Fabian
Jablawi, Fidaa
Uhl, Eberhard
Koch, Christian
Sander, Michael
Funding for this research was provided by:
Justus-Liebig-Universität Gießen
Article History
Received: 1 September 2022
Accepted: 16 December 2022
First Online: 23 December 2022
Declarations
:
: Ethical approval for this study (AZ 258/19) was provided by the local ethics committee of the medical faculty of the Justus-Liebig-University, Giessen, Germany on 13 March 2020, and this trial was registered with the German Clinical Trials Register (DRKS00022917). All methods were carried out in accordance with relevant guidelines and regulations (Declaration of Helsinki and international and national standards/regulations). Informed consent to participate was obtained from all subjects or their legal guardian(s).
: Not applicable.
: Michael Sander and Emmanuel Schneck are consultants for Edwards Lifesciences. All other authors declare that they have no conflict of interest.